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ARTICLE
Copper amine oxidases catalyze the oxidative
deamination and hydrolysis of cyclic imines
Toshiki Nagakubo1, Takuto Kumano1, Takehiro Ohta 2,3, Yoshiteru Hashimoto1 & Michihiko Kobayashi1
Although cyclic imines are present in various bioactive secondary metabolites, their degra-
dative metabolism remains unknown. Here, we report that copper amine oxidases, which are
important in metabolism of primary amines, catalyze a cyclic imine cleavage reaction. We
isolate a microorganism (Arthrobacter sp. C-4A) which metabolizes a β-carboline alkaloid,
harmaline. The harmaline-metabolizing enzyme (HarA) puriﬁed from strain C-4A is found to
be copper amine oxidase and catalyze a ring-opening reaction of cyclic imine within har-
maline, besides oxidative deamination of amines. Growth experiments on strain C-4A and
Western blot analysis indicate that the HarA expression is induced by harmaline. We pro-
pose a reaction mechanism of the cyclic imine cleavage by HarA containing a post-
translationally-synthesized cofactor, topaquinone. Together with the above results, the
ﬁnding of the same activity of copper amine oxidase from E. coli suggests that, in many living
organisms, these enzymes may play crucial roles in metabolism of ubiquitous cyclic imines.
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β-Carboline alkaloids comprise a large group of indolealkaloids. They are widely distributed secondary metabolites
in nature and exhibit remarkable bioactivities1. Some of
them are candidate therapeutic agents for drug abuse1. In addi-
tion, β-carboline alkaloids such as reserpine (antihypertensive),
yohimbine (α-receptor antagonist), eudistomin (antivirus, etc.),
and mitragynine (opioid-receptor agonist) have been studied
pharmacologically; in particular, the former two compounds have
been used as medicines.
β-Carboline alkaloids are biosynthesized from tryptamine (or
tryptophan) and an aldehyde through the Pictet–Spengler reaction.
While this ring-closing reaction has been considered to be catalyzed
by Pictet–Spenglerase family enzymes in nature, recent studies have
shown that there is another enzyme family that synthesizes β-
carboline alkaloids2–5. As endogenous compounds, possibly due to
the wide distribution of these enzymes among organisms, β-
carboline alkaloids are ubiquitously produced by broad species of
plants, microorganisms and animals, including humans6,7.
Although the biosynthesis of β-carboline alkaloids has been
revealed, as described above, their degradative metabolism is
unclear.
Peganum harmala is well-known as a medicinal plant, exhi-
biting cardiovascular, anti-depressant, antitumor and anti-
bacterial effects6. Harmaline, one of the simplest β-carboline
alkaloids, is responsible for these effects of P. harmala. Various
parts of P. harmala including its seeds, fruit, roots and bark have
been ingested as folk medicines for a long time in Middle Eastern,
African and European countries6. Unique biological functions of
harmaline, which is a bioactive compound in P. harmala, have
been investigated, such as (i) an increasing effect on NO-release
from endothelial cells, (ii) an inhibitory effect on monoamine
oxidase A, and (iii) binding abilities with DNA, RNA and various
receptors in the central nervous system6. While the worldwide use
and such bioactivities of harmaline have attracted the interest of
researchers for decades, to the best of our knowledge, degradation
of harmaline has never been reported. As harmaline should exist
in the soil in which a harmaline-producing plant, such as P.
harmala, grows, we hypothesized that harmaline is degraded and
metabolized by microorganisms in the soil.
Here, we describe the discovery of copper amine oxidase
(CAO) as a harmaline-metabolic enzyme, from a harmaline-
metabolizing microorganism. We also propose a two-step reac-
tion mechanism for the cleavage of the C=N bond (in the unique
cyclic imine structure), and show the generality of the dual
functions of CAOs across species.
Results
Isolation and identiﬁcation of harmaline-metabolizing bacteria.
We collected the samples for the screening of harmaline-
metabolizing microorganisms from the soil around the root of P.
harmala, which was grown at the Tokyo Metropolitan Institute of
Public Health. At ~2 weeks from the start of the screening, using the
enrichment culture method described under Methods, we isolated
ﬁve microorganisms that were able to grow on minimum media
containing 0.025% (w/v) harmaline as the sole carbon source. From
the isolated microorganisms, we selected one isolate, strain C-4A,
that showed the highest harmaline-converting activity in the resting
cell reaction, for further studies. Notably, strain C-4A was also able
to metabolize harmaline as the sole nitrogen source.
Phylogenetic analysis revealed that the strain is closely related
to the genus Arthrobacter, showing 99% 16S rRNA gene sequence
similarity to an actinomycete, Arthrobacter nitroguajacolicus
G2–1.
Puriﬁcation of the harmaline-metabolizing enzyme. We incu-
bated cell-free extracts of strain C-4A with harmaline (Fig. 1a) as a
substrate. Liquid chromatography/mass spectrometry (LC/MS)
analysis revealed that a reaction product exhibitedm/z 230 [M−H]−
in the negative ion mode (Fig. 1b). Strain C-4A was cultured and
harvested in 48 L of the above minimum medium, and a harmaline-
metabolizing enzyme was then puriﬁed from the harvested cells by
hydrophobic interaction and anion exchange chromatographies
(Supplementary Table 1). The puriﬁed enzyme gave a single band
corresponding to a molecular mass of 71 kDa on SDS-PAGE
(Fig. 1c). The molecular mass of the native enzyme was shown to be
130 kDa on gel ﬁltration chromatography, indicating that this
enzyme consists of two identical subunits (Supplementary Fig. 1).
Identiﬁcation of the harmaline-metabolizing enzyme. We
determined the draft genome sequence for strain C-4A using a
next-generation sequencer. A local BLAST search was made for
the draft genome sequence using a partial amino acid sequence
(MHSPLFDSLTADEITMVSTL) of the puriﬁed enzyme. As a
result, the gene coding for the harmaline-metabolizing enzyme
(named HarA) was identiﬁed. The amino acid sequence of HarA
showed identity (41%) with that of copper amine oxidase (CAO)
of Arthrobacter globiformis8. Based on this ﬁnding, we examined
whether or not HarA exhibited amine oxidase activity. On LC/MS
analyses, we found that HarA catalyzed the oxidation of the
amine moieties of tryptamine and serotonin (1 mM each).
In addition, HarA was heterologously expressed in E. coli and
physicochemically characterized (Supplementary Figs. 2–5 and
Supplementary Note 1). These analyses revealed that HarA
contained Cu2+ and the coordinated metal ion would be essential
for HarA activity.
Time-dependent harmaline metabolism during cultivation.
Strain C-4A was grown in the minimum medium containing each
of glucose and harmaline as the sole carbon source (Fig. 1d). In
the medium containing harmaline as the sole carbon source,
strain C-4A exhibited full growth, degrading harmaline. Notably,
no HarA activity was detected in the cell-free extract when C-4A
was grown in the medium containing glucose as the sole carbon
source, although the activity was observed in the cell-free extract
cultured in the medium containing harmaline as the sole carbon
source. On immunoblot analysis, in addition, HarA was detected
in the cell-free extract of strain C-4A that was grown in the above
harmaline-containing medium (Fig. 1e).
Structure determination of the reaction product. We next
determined the structure of the reaction product that was yielded
through HarA-catalyzed harmaline degradation and detected on
LC/MS analysis (Fig. 1b). Structural analyses of the 2,4-dini-
trophenylhydrazine (DNPH)-derivatized reaction product
revealed that harmaline was converted into a compound, 2-
acetyl-1H-indol-6-methoxy-3-acetaldehyde (2-AIMA), by HarA
(Fig. 2a, b, Supplementary Figs. 6–11, Supplementary Table 2 and
Supplementary Note 2). We then conﬁrmed that HarA formed no
by-product; during the HarA-catalyzed harmaline-degrading
reaction, only the peak derived from 2-AIMA was observed in the
LC chromatogram and MS spectrum of the corresponding
compound (Supplementary Fig. 12).
Furthermore, 2-AIMA was found to be metabolized to a stable
alcohol metabolite by strain C-4A (Supplementary Figs. 13–18,
Supplementary Table 3 and Supplementary Note 3).
Identiﬁcation of other reaction products and stoichiometry.
Identiﬁcation of one of the reaction products as 2-AIMA, which
is a indole derivative containing acetaldehyde and acetyl groups,
indicated that the nitrogen atom of the cyclic imine within har-
maline was removed through a HarA-catalyzed reaction. We thus
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investigated whether or not any nitrogen-containing compounds,
such as HNO, NO, NO2−, NO3−, and NH3, could be detected
during harmaline degradation. As a result, only NH3 was detected
successfully (Supplementary Fig. 19). In addition, we found that
H2O2 was also produced through HarA-catalyzed harmaline
degradation. Also, HarA showed no activity under strict anae-
robic conditions. These ﬁndings indicated that O2 acted as an
electron acceptor and was converted into H2O2 in HarA-
catalyzed harmaline degradation.
The stoichiometry of HarA-catalyzed harmaline degradation
was examined. Consumption of O2 and formation of 2-AIMA,
NH3 and H2O2, were stoichiometric with consumption of
harmaline (Fig. 2c–f). In addition, we found that two oxygen
atoms of 2-AIMA would be derived from H2O (Fig. 2g, h,
Supplementary Figs. 20, 21 and Supplementary Note 4). Based on
these ﬁndings, we determined HarA-catalyzed harmaline degra-
dation as follows: C13H14N2O (harmaline)+O2+ 2H2O →
C13H13NO3 (2-AIMA)+NH3+H2O2 (Fig. 2i).
Identiﬁcation of topaquinone of HarA. As described under
Identiﬁcation of the harmaline-metabolizing enzyme, HarA
showed sequence similarity to CAO. CAOs contain a post-
translationally-synthesized cofactor, topaquinone (TPQ), in their
active sites. The UV-vis spectrum of HarA showed a peak, whose
λmax (489 nm, Fig. 3a) corresponded to that (470–500 nm) of
TPQ in so far known CAOs. On the other hand, Cu-depleted
HarA, which was heterologously expressed in M9 medium
without the addition of Cu2+, showed extremely low levels of
TPQ generation and harmaline-converting activity (Fig. 3a, b).
TPQ was also detected as a phenylhydrazine adduct in the non-
apeptide (Ile-Ala-Thr-Ile-Gly-Asn-TPQ-His-Tyr) that was
derived from phenylhydrazine-treated HarA (Fig. 3c–e). The ratio
of TPQ to HarA monomer was calculated by phenylhydrazine
titration to be approximately 1:3 (Supplementary Fig. 22).
The previous study9 has revealed that the C5 oxygen of TPQ is
speciﬁcally labeled when the CAO from Arthrobacter globiformis
is exposed to H218O. This 18O-substitution of the C5 oxygen has
been demonstrated by Raman spectroscopic analyses, in which
the frequency of the C5=O stretch shifted to lower energy
through 18O-substitution. Using H218O, we thus tried to identify
the C5=O stretching band of TPQ in the Raman spectrum of
HarA by means of the 18O-substitution. When HarA was exposed
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Fig. 1 Discovery of a harmaline-metabolizing enzyme. Harmaline-metabolizing enzyme HarA was found from strain C-4A. a Structure of harmaline. b LC/
MS analyses of the reaction product of harmaline. Reaction mixtures containing harmaline and each of a cell-free extract of strain C-4A and puriﬁed HarA
were incubated and then analyzed at 330 nm. The arrow indicates the reaction product that exhibits m/z 230 [M−H]− in the negative ion mode. c SDS-
PAGE of puriﬁed HarA. Lane M, marker proteins: phosphorylase b (97 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase
(30 kDa), soybean trypsin inhibitor (20.1 kDa), and α-lactalbumin (14.4 kDa). The ﬁnal concentration and purity of HarA were 0.186mgml−1 and ~95%,
respectively. Source data are provided as a Source Data ﬁle. d Time courses of cell growth, harmaline concentration and speciﬁc activity (SA) for harmaline
degradation in cell-free extracts during culture using media that contained harmaline or glucose as the sole carbon source. All the experiments were
conducted in triplicate, and all data points represent the mean values ± S.D. for three experiments. Source Data are provided as a Source Data ﬁle.
e Western blot analyses for puriﬁed HarA and cell-free extracts of C-4A grown in each of the media in d. The amount of puriﬁed HarA (left) was 20 ng.
The amounts of cell-free extracts of C-4A grown in media containing harmaline (center) or glucose (right) as the sole carbon source were 15 μg. Source
data are provided as a Source Data ﬁle
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to H218O, the C=O stretching band at 1670 cm−1 underwent a
24 cm−1 shift to lower energy with no shifts of other peaks
(Fig. 3f, g). In addition, the frequency at 1670 cm−1 was similar to
those of the C5=O stretches of TPQs of CAOs from A.
globiformis (1683 cm−1), E. coli (1681 cm−1), and bovine serum
(1678 cm−1)9. Thus, the oxygen isotope-sensitive band at 1670
cm−1 can be assigned as the C=O stretching mode of the C5
carbonyl of TPQ of HarA.
Substrate speciﬁcity and kinetic properties of HarA. We
examined the substrate speciﬁcity of HarA using linear (N-ben-
zylidenemethylamine and N-benzylideneaniline) or cyclic (2-
methylenepiperidine [MP]) imine substrates (Supplementary
Fig. 23). Among them, MP was found to be a substrate for
HarA. The results of LC/MS and photometric analyses indicated
that HarA cleaved the C-N bonds of MP to yield 5-oxohexanal
and H2O2 (Fig. 4a, b). Linear imine substrates were inert
for HarA.
Using various concentrations of harmaline and MP, we
examined the kinetic properties of HarA. Typical hyperbolic
curves of product formation for each of the harmaline and MP
concentration were obtained, which indicated that the reactions
followed Michaelis–Menten kinetics (Fig. 4c, d). The Km value
(1.70 mM) of HarA-catalyzed MP degradation was 3.87-fold
higher than that (0.439 mM) of harmaline degradation. On the
other hand, the Vmax value (0.280 nmol min−1 mg−1) of HarA-
catalyzed MP degradation was 9.89-fold lower than that (2.77
nmol min−1 mg−1) of harmaline degradation. These ﬁndings
indicate that the aromatic ring moiety was important for the
interaction between an imine substrate and HarA.
In addition, we also examined the substrate speciﬁcity of HarA
toward amine substrates. HarA-catalyzed oxidations of aromatic
substrates (tryptamine and benzylamine) were much faster than
those of linear substrates (methylamine, ethylamine, hexylamine,
and octylamine) (Supplementary Fig. 24).
Construction and functional analyses of HarA mutants. The
results of amino acid sequence alignment of HarA and CAO from
E. coli (ECAO) indicated that four amino acid residues (Y281,
D295, N378, and Y379) were conserved between ECAO and
HarA, and located around the active site of HarA (Supplementary
Fig. 25). D467, which would contribute to the stability of TPQ in
ECAO10, was not conserved in HarA and corresponded to H380
of HarA in the sequence alignment.
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Through single-amino acid substitution of each of the above
amino acid residues, we constructed a set of mutants (i.e., Y281A,
D295A, D295E, N378A, Y379F, and H380A, Supplementary
Fig. 26). Among these mutants, the D295A, D295E, and Y379F
ones were found to be completely inactive as to harmaline
degradation (Fig. 5a, b). Even after overnight incubation, these
mutants produced no reaction product. In addition, the D295A
and Y379F mutations completely abolished the amine oxidase
activity of HarA (Fig. 5c). On the other hand, D295E mutant
catalyzed deamination of tryptamine, although the activity was
less than that of wild-type enzyme (Fig. 5c). The results of
spectroscopic analysis, and amino acid sequence alignment of
HarA and ECAO indicated that Y379 is a precursor of TPQ
(Supplementary Fig. 25, Fig. 3a). Considering the previous
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results10,11, the other tested amino acid residues would contribute
to the stability of TPQ and the substrate speciﬁcity of the enzyme.
Spectroscopic analyses of reaction intermediates. We spectro-
scopically analyzed reaction intermediates of harmaline degra-
dation and oxidation of the amine moiety of an amine substrate.
For Raman and UV-vis spectroscopic analyses, we were not able
to use harmaline as a substrate for HarA for the following rea-
sons: (i) the ﬂuorescence of harmaline would have interfered with
Raman spectroscopic analysis, and (ii) an absorbance band of
harmaline in the UV-vis spectrum overlapped with that of TPQ.
We thus used MP, which is not ﬂuorescent and exhibits no
absorbance above 300 nm in a UV-vis spectrum, as an imine
substrate instead of harmaline in the following experiments.
For a clear picture of the resonance-enhanced modes of the
TPQ cofactor, difference Raman spectra for HarA were obtained
by subtracting the Y379F mutant spectra from that of native
HarA (Supplementary Fig. 27). In the Raman spectrum of HarA
with benzylamine, the C5=O stretching band at 1670 cm−1
disappeared, whereas some peaks appeared (Fig. 5d). These
spectroscopic features were almost identical with those of a
deprotonated imine intermediate of TPQ, which had been
previously reported as the reaction intermediate of CAOs with
amine substrates9. Notably, a newly appeared resonance-
enhanced peak at 1600 cm−1 is indicative of the formation of
an imine, which shows a C=N stretching band at the similar
energy region9. When MP was used as a substrate, again the
C5=O stretching band at 1669 cm−1 disappeared, while the
overall spectral feature is quite different from an imine
intermediate formed in the reaction with benzylamine (Fig. 5d).
In addition, when HarA reacted with MP, λmax of TPQ in the
UV-vis spectrum shifted to around 460 nm from 489 nm (Fig. 5e).
These spectroscopic features strongly suggested the existence of a
reaction intermediate other than an imine intermediate of TPQ,
when the substrate was a cyclic imine.
Harmaline-degrading activity of CAO from E. coli. We inves-
tigated whether or not another CAO could catalyze harmaline
degradation. The CAO-coding gene (tynA)12 was ampliﬁed
from the genome of E. coli DH10B. An expression plasmid
containing tynA was then constructed and introduced into
E. coli DH10B. CAO from E. coli (ECAO) was expressed in
E. coli BL21-CodonPlus(DE3)-RIL and puriﬁed (Fig. 6a). The
puriﬁed ECAO was able to convert harmaline into 2-AIMA
(Fig. 6b). However, the harmaline-degrading activity of E. coli
DH10B was not induced on the addition of harmaline to the
culture medium.
Discussion
β-Carboline alkaloids have attracted interest due to their
remarkable bioactivities. For example, mitragynine, which is
present in kratom (Mitragyna speciosa) leaves, is one of the β-
carboline alkaloids and has been investigated as a substitute for
opium or as a cure for opium addiction13. Harmaline is also a β-
carboline alkaloid and produced by many living organisms; it
exists in humans14. One of the organisms is Banisteriopsis caapi
(Malpigbiaceae), from which Amazonian tribes make a botanical
beverage, Ayahuasca, for sacred rituals. Ayahuasca is famous for
its strong hallucinogenic activity, and has the potential for
medical use as a cure for drug addiction, depression, and anxiety
disorders15. Notably, unique functions of harmaline, such as
inhibition of monoamine oxidase A, are considered to contribute
to these bioactivities. In addition, harmaline and harmine, which
is a dehydrogenated derivative of harmaline, have been shown to
exhibit potential therapeutic activity against diabetes16. Drug
addiction, psychiatric diseases and diabetes are social problems in
many countries, and β-carboline alkaloids may be keys for coping
with such problems. On the other hand, the knowledge of their
metabolism is limited. In mammals, only O-demethylation,
hydroxylation, and dehydrogenation are known as metabolic
reactions for harmaline17,18.
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In nature, imines are generated through numerous metabolic
pathways, such as biosynthetic pathways for secondary metabo-
lites19. In addition, cyclic imines are present in the substructures
of various bioactive secondary metabolites; e.g., gymnodimine
(antagonist for nicotinic acetylcholine receptors)20,21, koranimine
(antibiotic)22, and venoms of ﬁre ants (inhibitors of nitric oxide
synthase)23. Synthetic cyclic imine sugars as potent inhibitors of
various glycosidases are of medicinal importance24. Notably, in
contrast to linear imines, cyclic imines are generally stable and
hardly undergo hydrolysis. In fact, cyclic imine within harmaline
was found to be stable with the respect to the spontaneous
hydrolysis in water (Supplementary Fig. 28 and Supplementary
Note 5). As far as we know, cyclic imine-opening enzymes have
never been previously found; cleaving activity of CAO toward
cyclic imines including harmaline has never been reported.
Although ﬂavin-dependent monoamine oxidases (MAOs) cata-
lyze similar oxidative deamination to that of CAOs, notably,
harmaline and its derivatives have been known to be a strong
competitive inhibitor of MAOs rather than their substrate25.
Therefore, harmaline-degrading activity would be a unique fea-
ture of CAOs.
CAOs contain TPQ, which is considered to be generated via
self-oxidation of the speciﬁc tyrosine residue by coordinated
Cu2+ in their active sites26,27. Similar to TPQ, some cofactors,
such as lysine tyrosylquinone (LTQ) and tryptophan trypto-
phylquinone (TTQ), are also known to be post-translationally
generated from speciﬁc amino acid residues28. Among them,
TPQ is the most ubiquitous, because TPQ-containing CAOs are
widely distributed in bacteria, yeast, fungi, plants, and animals.
This ﬁnding indicates that these CAOs are also able to catalyze
imine-cleaving reactions if imine substrates bind to the active
sites of the enzymes. Indeed, CAO from E. coli (ECAO), which
shares similar substrate speciﬁcity for amine-oxidizing activity
toward aromatic substrates29 with HarA, also exhibited
harmaline-metabolizing activity (Fig. 6). In addition, human
CAOs, such as AOC2 (retina-speciﬁc copper amine oxidase) and
AOC3 (vascular adhesion protein, VAP-1), are known to have
substrate speciﬁcities that are similar to those of HarA and
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ECAO; these enzymes are more speciﬁc for aromatic substrates,
such as benzylamine or tryptamine, than methylamine or
ethylamine30,31. Although overall amino acid sequences of ECAO
and AOC3 exhibit low sequence identity (29%) with each other,
their active site arrangements are similar to each other (Supple-
mentary Fig. 25b)12,32. Moreover, notably, harmaline or its
derivatives have been detected in human tissues such as the eyes
of cataract patients, where AOC2 is speciﬁcally expressed7,33.
Therefore, these observations indicate that β-carboline-
metabolizing pathways involving CAOs may also be present in
humans and other living organisms. The implication of the
existence of the above metabolism in humans is important,
because β-carboline alkaloids, including harmaline, have been
shown to be endogenous compounds and to have therapeutic
potency as to various diseases6,15,33.
Many studies have been performed to elucidate the mechanism
of CAO-catalyzed amine oxidation. In the proposed mechan-
ism34–36, TPQ forms substrate Schiff base with the substrate, an
amine. Substrate Schiff base is converted into product Schiff base
and then hydrolyzed by the aspartate residue in the active site of
CAO, releasing an aldehyde product. Next, the copper ion acti-
vates O2 to accept electrons from the resulting semiquinone.
Subsequently, NH3, H2O2, and TPQ are generated.
The results of single-amino acid mutagenesis showed that
Asp295 of HarA is crucial for enzyme activity toward both har-
maline and amine substrates. In addition, we concluded that
coordination of the copper ion in the active site of HarA is
essential for TPQ formation and HarA-catalyzed harmaline
degradation, for the following reasons: (i) addition of Cu2+ to M9
medium was required for heterologous expression of HarA that
contained the post-translationally-synthesized TPQ; (ii) chelating
reagents (e.g., EDTA and diethyldithiocarbamate) decreased the
activity of HarA; and (iii) the copper content of HarA was almost
equivalent to that of TPQ. As the aspartate residue and copper
ion have been shown to also be crucial for CAO-catalyzed amine
oxidation34–36, the above results indicate that amine oxidation
and harmaline-degrading reaction share these catalytic compo-
nents (aspartate residue and copper ion).
A semiquinone intermediate has been identiﬁed as one of the
reaction intermediates (which are derived from TPQ) of CAO-
catalyzed amine oxidation9. A previous study9 revealed that the
semiquinone intermediate showed a weak resonance Raman
effect and a peak at around 460 nm in the UV-vis spectrum. As
these features are similar to those of a reaction intermediate of
HarA with MP, it is indicated that this intermediate was also
observed in our experiment. The existence of semiquinone in
both HarA-catalyzed MP degradation and deamination of amine
substrates suggests that these reactions proceed via the formation
of so far known intermediates (i.e., substrate Schiff base, product
Schiff base, aminoquinol and semiquinone) of CAO-catalyzed
amine oxidation (Supplementary Fig. 29a). Based on the above
ﬁndings, we propose that harmaline is degraded into 2-AIMA
through a reaction mechanism that involves TPQ as a redox
cofactor (Fig. 7a).
The previous study9 shows that some amine substrates form an
inactive deprotonated imine intermediate with TPQ. Although
substrate Schiff base and product Schiff base are unstable, the
above inactive deprotonated imine intermediate is detectable on
Raman spectroscopy. In our resonance Raman spectroscopic
analyses, we observed a benzylamine adduct, which would be the
inactive deprotonated imine intermediate, in HarA (Fig. 5d and
Supplementary Fig. 27a). In the proposed reaction mechanism of
CAOs9, nucleophilic attack on product Schiff base by H2O is
facilitated by protonation of the intermediate. As reported pre-
viously for the methylamine adducts of phenylethylamine oxidase
and bovine serum amine oxidase9, the deprotonated and inactive
state of the benzylamine adduct of HarA may be favored by
ﬂipping of TPQ and interaction with copper or amino acid
residues under anaerobic conditions (Supplementary Fig. 29b).
Here, HarA and ECAO were found to convert harmaline
into 2-AIMA that included two oxygen atoms derived from H2O.
One of these oxygen atoms would be incorporated into 2-AIMA
through hydrolysis of product Schiff base. On the other hand,
the other H2O-derived oxygen atom would be added to
harmaline through nucleophilic attack by activated H2O on
an electrophilic carbon before the formation of substrate Schiff
base. The above result of oxygen incorporation suggests that
H2O is activated in the initial step of the reaction by any of
the active site components, which are polar amino acid residues,
TPQ and copper. Considering the previous observations37,38,
however, TPQ and copper are not likely to act as base catalysts
for H2O activation in the imine-opening reaction for the fol-
lowing reasons: (i) the hydroxyl group at C4 of TPQ forms
hydrogen bond with nearby tyrosine residue; and (ii) copper is
distant from C5=O, with which an imine substrate would form
product Schiff base (Supplementary Fig. 25b), of TPQ in the
resting state. On the other hand, D295E mutant catalyzed the
deamination of tryptamine, although this enzyme completely
lacked harmaline-degrading activity (Fig. 5a–c). These results
indicate that HarA lost the ability for the hydrolysis of
harmaline through D295E mutation, while Glu295 could act as an
active site base instead of Asp295 for oxidative deamination of an
amine substrate, as previously reported for CAOs of E. coli39.
Therefore, Asp295 may play an essential role for the hydrolysis of
cyclic imine, and length of the side chain of the amino acid
residue would be crucial for the activity. Based on our results and
the previous observations34–40, we here propose a possible reac-
tion mechanism in which H2O is activated by the active site
component(s), such as Asp295, and the resultant activated H2O
attacks on the electrophilic carbon of C=N within cyclic imine
(Fig. 7b and Supplementary Fig. 29c); cyclic imine would be
opened through the above hydrolytic reaction, and then form
substrate Schiff base with TPQ. Therefore, CAOs would be
unique dual functional enzymes catalyzing cyclic imine hydrolysis
besides oxidative deamination of amine substrates. Future studies
are necessary to clarify the detailed mechanism of harmaline
degradation.
It is possible that the hydrolysis of cyclic imine within har-
maline starts from the corresponding enamine. However, we
consider that the hydrolysis of imine would be more likely than
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Fig. 6 Harmaline-degrading activity of copper amine oxidase from E. coli.
Copper amine oxidase (CAO) from E. coli (ECAO) was overexpressed in E.
coli and puriﬁed. a SDS-PAGE of puriﬁed ECAO. Source data are provided
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that of the enamine isomer in HarA-catalyzed harmaline degra-
dation for the following reasons: (i) carbon atoms of C=C of the
enamine are likely to be more electron-rich than the imine due to
the presence of adjacent electron-donating nitrogen atom, and (ii)
although protonation of C=C by an acid catalyst would be
required for hydration of the enamine, the results of site-directed
mutagenesis analyses of HarA show that there was no candidate
amino acid residue which acts as the acid catalyst in HarA.
Therefore, we concluded that the hydrolysis of the imine within
harmaline would be the ﬁrst step of HarA-catalyzed harmaline
degradation.
The crystal structure of ECAO has revealed that one water
molecule formed hydrogen bonds with aspartate residue and
C5=O of TPQ in an active state of the enzyme40. In addition, we
found that substitution of TPQ with Phe completely abolished
harmaline-degrading activity of HarA (Fig. 5a, b). These obser-
vations and our results indicate that an active site environment
which is created by TPQ and other amino acid residues would be
a key for the ring-opening reaction of cyclic imines that are
generally stable and hardly undergo hydrolysis. Involvement of
TPQ may explain why harmaline was not degraded by imine
reductases that catalyze hydrogenation of cyclic imine within
harmaline although aspartate residue is considered to act as a
proton donor in their active sites41.
In the present study, we show that a certain tyrosine residue of
a harmaline-metabolizing enzyme, which is copper amine
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oxidase, is post-translationally modiﬁed in the presence of a
copper ion and the resulting modiﬁed residue is involved in the
harmaline-degrading reaction. Our ﬁndings would extend
understanding of the catalytic abilities of ubiquitous and exten-
sively studied CAOs. The dual functions of CAOs described here
will lead to further elucidation of unidentiﬁed physiological roles
of the enzymes.
Methods
Materials. Harmaline, tryptamine and serotonin were purchased from Tokyo
Kasei Kogyo Co., Ltd. (Tokyo, Japan). N-Benzylidenemethylamine, N-benzylide-
neaniline, benzylamine, methylamine, and ethylamine were purchased from Wako
Pure Chemical Industries, Ltd. (Osaka, Japan). 2-Methylenepiperidine was pur-
chased from Enamine (Monmouth, NJ, USA). N-Ethyl-N-(2-hydroxy-3-sulfopro-
pyl)-3,5-dimethoxyaniline was purchased from Dojindo (Kumamoto, Japan). All
other chemicals used were from commercial sources and of analytical grade.
Resource Q, HiPrep DEAE FF 16/10 and a low molecular weight standard kit were
obtained from GE Healthcare (Buckinghamshire, UK).
Isolation of harmaline-metabolizing microorganisms. Harmaline-metabolizing
microorganisms were isolated from soil samples as follows. A spoonful of a soil
sample around the roots of Peganum harmala was added to a test tube containing
10 ml of a screening medium (pH 7.0) consisting of 0.1% (w/v) (NH4)2SO4, 0.05%
(w/v) K2HPO4, 0.05% (w/v) KH2PO4, 0.05% (w/v) MgSO4·7H2O, 0.0005% (w/v)
FeSO4·7H2O, 0.025% (w/v) harmaline, and 20% (v/v) tap water. After incubation at
28 °C for 7 days, 1% (v/v) of the cultivated medium was added to the same fresh
medium, followed by incubation at 28 °C for 7 days. This step was repeated two
times. After enrichment, the culture broth was spread on agar plates, containing 1%
(w/v) agar in the above screening medium, followed by incubation at 28 °C for
3 days. Colonies that grew on these plates were then isolated. Each of the isolated
strains was inoculated into a test tube containing the above liquid screening
medium, followed by incubation at 28 °C for 3 days. Cells were harvested by
centrifugation (4000 × g, 10 min, 4 °C). After washing twice with 20 mM Hepes-
NaOH (pH 7.0), cells were resuspended in the same buffer. Resuspended cells were
then disrupted by sonication, and centrifuged (27,000 × g, 10 min, 4 °C) to prepare
a cell-free extract.
Enzyme assays. All of the reactions were performed under linear conditions with
an appropriate amount of protein and a suitable reaction time, unless otherwise
noted. Measurement of enzyme activity was performed as follows. One hundred
microliters of the reaction mixture contained 0.05–1 mgmL−1 HarA, 20 mM
Hepes-NaOH (pH 7.0), and 0.5–1 mM substrate (in DMSO). The reaction was
initiated by adding the enzyme, followed by incubation at 28 °C. After incubation,
the reaction was stopped by adding 100 μL of acetonitrile. The protein con-
centrations were determined with a protein assay kit (Nacalai Tesque Co., Inc.,
Kyoto, Japan) using bovine serum albumin as the standard, according to the
method of Bradford42.
Liquid chromatography and mass spectrometry. LC/MS analyses were carried
out using a Prominence system with a photodiode array detector (SPD-M20A) and
an LCMS-8030 (Shimadzu, Kyoto, Japan) equipped with a COSMOSIL πNAP
column (4.6 × 150 mm; Nacalai Tesque Co., Inc.). The HPLC conditions were as
follows: ﬂow rate, 1 mLmin−1; temperature, 40 °C; solvent A, 0.05% (v/v) formic
acid; and solvent B, acetonitrile. After column equilibration with 100% solution A,
10 μl of a sample was injected into the column. The sample were eluted from the
column by increasing the concentration of solvent B from 0 to 100% over 12 min.
Puriﬁcation of the harmaline-metabolizing enzyme. All puriﬁcation procedures
were performed at 0–4 °C. Cell-free extracts containing HarA were prepared as
described above and fractionated with ammonium sulfate (35–80% saturation).
The fractionated solutions were then applied to a Hiprep Butyl FF 16/10 column
(20 mL) equilibrated with 20 mM Tris-HCl buffer containing 1M ammonium
sulfate (pH 7.5 at 4 °C). Protein was eluted from the column by decreasing the
concentration of ammonium sulfate linearly from 1 to 0M in the same buffer. The
active fractions were collected and then dialyzed against 10 mM Tris-HCl buffer
(pH 8.0 at 4 °C). The protein solution was applied to a Resource Q column (6 mL)
equilibrated with 20 mM Tris-HCl (pH 8.0 at 4 °C). The protein was eluted by
increasing the concentration of NaCl linearly from 0 to 400 mM in the same buffer.
The active fractions were collected and then dialyzed as described above. The
protein solution was applied to a BioAssist Q column (Tosoh Co., Ltd., Tokyo,
Japan) equilibrated with the buffer used for Resource Q. Protein was eluted from
the column by increasing the concentration of NaCl linearly from 0 to 400 mM in
the same buffer.
Cell-free extracts containing ECAO were applied to a Hiprep DEAE FF 16/10
column (20 mL) equilibrated with 20 mM Tris-HCl buffer (pH 8.0 at 4 °C). Protein
was eluted from the column by increasing the NaCl concentration linearly from 0
to 1M in the same buffer.
Draft genome sequence of strain C-4A. Strain C-4A was cultured at 28 °C for
16 h in 100 mL of 2× YT media. Cells were harvested and then washed with saline-
EDTA (pH 8.0) containing 0.15 M NaCl and 0.1 M EDTA. In total, 1 mg mL−1 of
lysozyme and 0.0867 mgmL−1 of proteinase K were added to the resultant sus-
pension (11 mL) and incubated at 37 °C for 1 h. After incubation, 2 mL of 10% SDS
was added to the solution and incubated at 55 °C for 1 h. DNA was extracted by
phenol/chloroform/isoamylalcohol (25/24/1; v/v/v). After isopropanol precipita-
tion of the DNA, the sample was treated with RNase. The treated DNA was
extracted by isopropanol precipitation again. An Illumina Hiseq platform (Illu-
mina, Inc., San Diego, CA, USA) was used for draft genome sequencing of strain C-
4A. MiGAP (http://www.migap.org) was used for annotation of the draft genome
sequence.
Cloning and heterologous expression of harA and tynA. Bacterial strains and
plasmids used in the following experiments are listed in Supplementary Table 4.
harA was ampliﬁed using the genome of strain C-4A and the listed primers
(Supplementary Table 5). The ampliﬁed harA gene was integrated with pETDuet-1
vector by In-Fusion (Clontech Laboratories Inc.). The resulting plasmid named
pETDuet-harA was transformed into E. coli BL21-CodonPlus(DE3)-RIL. The
transformed E. coli was cultivated in 16 L of liquid M9 media containing 5 μM
CuSO4, 50 μg mL−1 ampicilin and 34 μg mL−1 chloramphenicol at 37 °C to an
OD600 of 0.3. Isopropyl-β-D-thiogalactoside (IPTG) was added to a ﬁnal con-
centration of 0.1 mM. After IPTG addition to the media, E. coli was cultivated at
18 °C for 20 h. Cells were harvested and disrupted by sonication. The lysate was
centrifuged at 27,000 × g at 4 °C for 20 min. HarA was puriﬁed from the resultant
cell-free extract by the method described under Puriﬁcation of the harmaline-
metabolizing enzyme.
tynA, which is the gene coding for copper amine oxidase, was ampliﬁed using
the genome of E. coli DH10B and the listed primers (Supplementary Table 5). The
ampliﬁed tynA gene was integrated with pET24a(+) vector by In-Fusion. The
resulting plasmid named pET24a(+)-tynA was transformed into E. coli BL21-
CodonPlus(DE3)-RIL. The copper amine oxidase was expressed by the above
method using kanamycin instead of ampicilin.
Determination of the molecular mass of HarA. HarA was applied to a Superdex
200 10/300 GL column (GE Healthcare UK Ltd., Little Chalfont, UK) using an
AKTA puriﬁer (GE Healthcare). HarA was eluted from the column under the
following conditions: ﬂow rate, 0.2 mLmin−1; and buffer, 20 mM potassium
phosphate buffer (pH 7.0) containing 200 mM NaCl. Thyroglobulin (670 kDa),
lactate dehydrogenase (142 kDa), enolase (67 kDa), and cytochrome c (12.4 kDa),
were applied before and after sample injection as standard proteins. The molecular
mass of HarA was calculated based on the standard curve obtained from the
mobilities of the standard proteins.
Effect of pH on HarA activity. For pH stability analyses, after HarA had been
incubated at 20 °C for 1 h in 20 mM Britton–Robinson buffer (pH 3.0–11.0), an
aliquot of each enzyme solution was taken and then assayed in the standard
reaction mixture. HarA activity was measured by HPLC. For pH dependency
analyses, the reaction mixture containing 80 mM Britton–Robinson buffer (pH
3.0–11.0) was incubated at 28 °C, and then analyzed by HPLC.
Western blot analysis. Proteins were separated by SDS-PAGE and then elec-
troblotted onto PVDF membranes (SequiBlotTM, Bio-Rad Laboratories, Inc.,
Hercules, CA, USA). After blocking with 3% (w/v) skim milk, the blots were
incubated with rabbit antiserum (diluted to 0.01%) directed against puriﬁed HarA
and cell-free extracts of strain C-4A at 4 °C for 15 h, and horseradish peroxidase-
conjugated secondary antibodies at room temperature for 80 min.
The immunoreactive proteins were detected with an ECL western blot detection
kit (GE Healthcare). An uncropped image of the blot is shown in Supplementary
Figure 31.
Derivatization of the reaction product. Harmaline was converted into the
reaction product using cell-free extracts of E. coli BL21-CodonPlus(DE3)-RIL
harboring pETDuet-harA. Derivatization of the reaction product was carried out as
follows. The reaction mixture was incubated with 80 μg mL−1 DNPH (in acet-
onitrile) and 40 mM citrate buffer (pH 3.0) at 40 °C for 1 h. The derivatized
reaction product was extracted with dichloromethane. The extract was evaporated
and the residue was dissolved in 1 mL of acetonitrile.
Structure determination of the reaction product. The derivative was puriﬁed by
HPLC with a Shimadzu LC-10-Avp system equipped with a COSMOSIL πNAP
20 × 150mm column (Nacalai Tesque) under the following conditions: column
temperature, 40 °C; isocratic elution; mobile-phase composition, 50% deionized
water/50% acetonitrile (v/v); ﬂow rate, 6 mLmin−1; and detection 500 nm. The
puriﬁed derivative was evaporated and the residue was dissolved in DMSO-d6. The
chemical structure of the derivative was elucidated by obtaining 1H NMR, 13C
NMR, HMBC and HMQC spectra using an AVANCE-600 NMR spectrometer
(Bruker, Billerica, MA, USA).
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Measurement of NH3. Measurement of NH3 via dansyl chloride derivatization: All
procedures were performed in the dark or under low light. One mM harmaline was
converted into the reaction product in 100 μL of the reaction mixture containing
HarA at 28 °C. After the reaction, 20 μL of 2 M NaOH, 30 μL of a saturated
NaHCO3 solution and 2 μL of 100 mM dansyl chloride were added to the reaction
mixture, followed by incubation at 40 °C for 1 h. Ten microliters of 100 mM proline
was then added to the reaction mixture, followed by further incubation at 40 °C for
30 min. After incubation, 100 μL of acetonitrile was added to the reaction mixture.
The resulting derivative was analyzed immediately by LC/MS.
Measurement of NH3 via NBD-F derivatization: All procedures were performed
in the dark or under low light. One millimolar harmaline was converted into the
reaction product in 100 μL of the reaction mixture containing HarA at 28 °C. After
the reaction, 80 μL of MeOH, 20 μL of 20 mM EDTA, and 70 μL of NBD-F (in
acetonitrile) were added to the reaction mixture, followed by incubation at 60 °C
for 1 h. The reaction mixture was then kept on ice. After addition of 270 μL of
50 mM HCl, the resulting derivative was analyzed immediately by LC/MS. NH3
was quantiﬁed by means of a standard curve obtained from the peak area of
derivatized authentic NH3 in the negative ion mode.
Measurement of H2O2. The reaction mixture comprising 0.45 mgmL−1 HarA,
20 mM Hepes-NaOH (pH 7.0), 1 mM harmaline, 1 mM N-ethyl-N-(2-hydroxy-3-
sulfopropyl)-3,5-dimethoxyaniline, 1 mM 4-aminoantipyrine, and 50 Uml−1
horseradish peroxidase was incubated at 28 °C. H2O2 was quantiﬁed using the
absorbance and extinction coefﬁcient of the blue pigment derived from N-ethyl-N-
(2-hydroxy-3-sulfopropyl)-3,5-dimethoxyaniline and 4-aminoantipyrine at 595
nm43.
Measurement of O2. O2 concentrations were measured with an oxygen electrode
(Hansatech Instruments Ltd., Norfolk, UK). The reaction was initiated by injecting
the enzyme solution (1 mL) into an electrode cuvette and carried out at 28 °C.
Site-directed mutagenesis. Site-directed mutagenesis of HarA was performed
using a KOD-plus mutagenesis kit (Toyobo Co., Ltd., Osaka, Japan). The primers
used in this experiment are listed in Supplementary Table 5. Plasmids containing
each of the Y291A, D295A, N378A, Y379F, and H380A mutants of harA gene were
transformed into E. coli BL21-CodonPlus(DE3)-RIL. The mutant enzymes were
overexpressed and puriﬁed using the transformed E. coli. Puriﬁcation procedures
were the same as those described in Puriﬁcation of the harmaline-metabolizing
enzyme.
Time courses of cell growth and enzymatic activity. Strain C-4A was cultured in
100 mL of liquid screening media containing harmaline as the sole carbon source
for 72 h at 28 °C. The cells were inoculated 1% (v/v) into 1 L of liquid screening
media containing each of harmaline or glucose as the sole carbon source, followed
by incubation for 60 h at 28 °C. During cultivation, 10 mL aliquots of cultures were
withdrawn at each check point for OD600 measurement, HPLC analysis of
supernatants and preparation of cell-free extracts. The cell-free extracts were
subjected to measurement of harmaline-degrading activity.
Identiﬁcation of topaquinone. Eight nmol of HarA was inactivated by the addi-
tion of 16 nmol of phenylhydrazine in two portions over a 1-h period. Using
Amicon Ultra-10k (Merck Millipore, Burlington, MA, USA), excess phenylhy-
drazine was removed by exchanging the buffer with 100 mM Tris-HCl (pH 8.0).
The derivatized enzyme was digested in a reaction mixture comprising 100 mM
Tris-HCl (pH 8.0), 10 mM CaCl2, and 25 μg chymotrypsin (Roche Diagnostics,
Basel, Schweiz). The reaction mixture was incubated at 25 °C for 4 h and then
analyzed by LC/MS. The LC/MS conditions were as follows: ﬂow rate, 1 mLmin−1;
solvent A, 0.05% (v/v) formic acid; solvent B, acetonitrile; and column, COSMOSIL
πNAP 4.6 × 150 (Nacalai Tesque). After column equilibration with 100% solution
A and 10 μl sample injection, a linear gradient system of acetonitrile, 0–100%, was
applied over 60 min at 40 °C. LC/MS/MS fragmentation of an ion exhibiting a m/z
value of 586 [M+2H]+ was conducted in the positive ion mode with collision
energy of −20 mV.
Resonance Raman spectroscopy. Resonance Raman analysis was carried out by
441.6 nm laser excitation (He-Cd laser (Kimmon Koha, IK4101R-F, Tokyo, Japan).
The scattered light was dispersed with a single polychromator (Chromex, 500IS,
Albuquerque, NM, USA), which was detected by a liquid-nitrogen-cooled CCD
detector (Roper Scientiﬁc, Spec10:400B/LN, Trenton, NJ, USA). Indene was used to
calibrate Raman shifts, giving an accuracy of ±1 cm−1 for intense Raman bands.
Reporting Summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The authors declare that all the relevant data supporting the ﬁndings of the study
are available in this article and its Supplementary Information ﬁles, or from the
corresponding author upon request. The source data ﬁles underlying Figs. 1c–e,
2c–f, 3a, 4b–d, 5a and 6a, and Supplementary Figs. 2–5, 22, 24, 26 and 28b are
provided as a Source Data ﬁle. The nucleotide sequence data reported in this paper
appear in the DDBJ/GenBank database under accession numbers LC384995 for
harA.
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